We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sandoz Group Ag | LSE:0SAN | London | Ordinary Share | CH1243598427 | SANDOZ GROUP ORD SHS |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 164,642 | - |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 18:52:24 | O | 421 | 29.3248 | CHF |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/4/2024 | 06:00 | UKREG | Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab),.. |
| 21/3/2024 | 13:00 | UKREG | Sandoz opens new antibiotic production facility in Austria, to.. |
| 13/3/2024 | 06:00 | UKREG | Sandoz reports fourth quarter 2023 sales and full-year 2023 results |
| 05/3/2024 | 18:24 | UKREG | Sandoz receives FDA approval for first and only denosumab biosimilars |
| 05/3/2024 | 06:00 | UKREG | Sandoz announces nominations to the Board of Directors and leadership.. |
| 04/3/2024 | 06:00 | UKREG | Sandoz acquires CIMERLI® business from Coherus, further building biosimilar.. |
| 29/2/2024 | 06:00 | UKREG | Sandoz US subsidiaries resolve generic drug antitrust class action.. |
| 01/2/2024 | 06:15 | UKREG | Sandoz announces changes in the Board of Directors |
| 31/1/2024 | 06:00 | UKREG | Sandoz launches first and only biosimilar for multiple sclerosis, Tyruko®.. |
Sandoz (0SAN) Share Charts1 Year Sandoz Chart |
|
1 Month Sandoz Chart |
Intraday Sandoz Chart |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
